Hemolytic-uremic syndrome laboratory findings: Difference between revisions
| Line 37: | Line 37: | ||
}}</ref> | }}</ref> | ||
[[Immunohistochemistry]] among patients with [[Hemolytic-uremic syndrome|HUS]] shows reach of [[Von Willebrand factor|VWF]]. | |||
[[Immunohistochemistry]] among patients with HUS shows | |||
Laboratory findings consistent with the diagnosis of [[HUS]] include:<ref>{{Cite journal | Laboratory findings consistent with the diagnosis of [[HUS]] include:<ref>{{Cite journal | ||
| Line 58: | Line 53: | ||
* | * | ||
*[[TAR syndrome|Thrombocytopenia]] | *[[TAR syndrome|Thrombocytopenia]] | ||
Some patients with [[Hemolytic-uremic syndrome|HUS]] may have bone marrow normal to increased megakaryocytes | Some patients with [[Hemolytic-uremic syndrome|HUS]] may have [[bone marrow]] normal to increased megakaryocytes . | ||
==References== | ==References== | ||
Revision as of 16:56, 9 August 2018
|
Hemolytic-uremic syndrome Microchapters |
|
Differentiating Hemolytic-uremic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hemolytic-uremic syndrome laboratory findings On the Web |
|
American Roentgen Ray Society Images of Hemolytic-uremic syndrome laboratory findings |
|
Risk calculators and risk factors for Hemolytic-uremic syndrome laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
OR
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
OR
[Test] is usually normal for patients with [disease name].
OR
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
OR
There are no diagnostic laboratory findings associated with [disease name].
Laboratory Findings
An elevated concentration of WBC, thrombocytopenia, normocytic anemia is diagnostic of HUS.[1][2]
Immunohistochemistry among patients with HUS shows reach of VWF.
Laboratory findings consistent with the diagnosis of HUS include:[3]
Some patients with HUS may have bone marrow normal to increased megakaryocytes .
References
- ↑ Kottke-Marchant, K. (2017). "Diagnostic approach to microangiopathic hemolytic disorders". International Journal of Laboratory Hematology. 39: 69–75. doi:10.1111/ijlh.12671. ISSN 1751-5521.
- ↑ A. H. Sutor, K. B. Thomas, F. H. Prufer, A. Grohmann, M. Brandis & L. B. Zimmerhackl (2001). "Function of von Willebrand factor in children with diarrhea-associated hemolytic-uremic syndrome (D+ HUS)". Seminars in thrombosis and hemostasis. 27 (3): 287–292. doi:10.1055/s-2001-15267. PMID 11446662. Unknown parameter
|month=ignored (help) - ↑ J. R. Brandt, L. S. Fouser, S. L. Watkins, I. Zelikovic, P. I. Tarr, V. Nazar-Stewart & E. D. Avner (1994). "Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers". The Journal of pediatrics. 125 (4): 519–526. PMID 7931869. Unknown parameter
|month=ignored (help)